137 related articles for article (PubMed ID: 36178567)
1. Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.
Islam KB; Brandman D; Chu JN; Goldman ML; Fox RK
Dig Dis Sci; 2023 Feb; 68(2):434-438. PubMed ID: 36178567
[TBL] [Abstract][Full Text] [Related]
2. Primary care practitioners survey of non-alcoholic fatty liver disease.
Said A; Gagovic V; Malecki K; Givens ML; Nieto FJ
Ann Hepatol; 2013; 12(5):758-65. PubMed ID: 24018493
[TBL] [Abstract][Full Text] [Related]
3. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
Patel PJ; Banh X; Horsfall LU; Hayward KL; Hossain F; Johnson T; Stuart KA; Brown NN; Saad N; Clouston A; Irvine KM; Russell AW; Valery PC; Williams S; Powell EE
Intern Med J; 2018 Feb; 48(2):144-151. PubMed ID: 29083080
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.
Nadolsky K; Cryer DR; Articolo A; Fisher T; Schneider J; Rinella M
Ann Med; 2023 Dec; 55(1):2211349. PubMed ID: 37171239
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.
Rigor J; Diegues A; Presa J; Barata P; Martins-Mendes D
Postgrad Med; 2022 May; 134(4):435-440. PubMed ID: 35332833
[TBL] [Abstract][Full Text] [Related]
6. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.
Pattison RJ; Esteban JP; Sempokuya T; Kewcharoen J; Kalathil S; Kuwada SK
Hawaii J Health Soc Welf; 2020 Jun; 79(6):180-186. PubMed ID: 32524096
[TBL] [Abstract][Full Text] [Related]
8. Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians.
Lee-Kim V; Morkem R; Barber D; Flemming JA; Kehar M
Paediatr Child Health; 2022 May; 27(2):93-98. PubMed ID: 35599680
[TBL] [Abstract][Full Text] [Related]
9. Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease.
Wieland AC; Quallick M; Truesdale A; Mettler P; Bambha KM
Dig Dis Sci; 2013 Oct; 58(10):2809-16. PubMed ID: 23843097
[TBL] [Abstract][Full Text] [Related]
10. Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease.
Prasoppokakorn T; Chan WK; Wong VW; Pitisuttithum P; Mahadeva S; Nik Mustapha NR; Wong GL; Leung HH; Sripongpun P; Treeprasertsuk S
World J Gastroenterol; 2022 Apr; 28(15):1563-1573. PubMed ID: 35582126
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study.
Shaheen AA; Riazi K; Medellin A; Bhayana D; Kaplan GG; Jiang J; Park R; Schaufert W; Burak KW; Sargious M; Swain MG
CMAJ Open; 2020; 8(2):E370-E376. PubMed ID: 32414883
[TBL] [Abstract][Full Text] [Related]
12. Advanced liver fibrosis and the metabolic syndrome in a primary care setting.
Schreiner AD; Zhang J; Durkalski-Mauldin V; Livingston S; Marsden J; Bian J; Mauldin PD; Moran WP; Rockey DC
Diabetes Metab Res Rev; 2021 Nov; 37(8):e3452. PubMed ID: 33759300
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.
Ampuero J; Pais R; Aller R; Gallego-Durán R; Crespo J; García-Monzón C; Boursier J; Vilar E; Petta S; Zheng MH; Escudero D; Calleja JL; Aspichueta P; Diago M; Rosales JM; Caballería J; Gómez-Camarero J; Lo Iacono O; Benlloch S; Albillos A; Turnes J; Banales JM; Ratziu V; Romero-Gómez M;
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):216-225.e5. PubMed ID: 31195161
[TBL] [Abstract][Full Text] [Related]
15. Step layered combination of noninvasive fibrosis models improves diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease.
Yang M; Jiang L; Wang Y; Li X; Zou Z; Han T; Nan Y; Lu F; Zhao J
J Gastrointestin Liver Dis; 2019 Sep; 28(3):289-296. PubMed ID: 31517325
[TBL] [Abstract][Full Text] [Related]
16. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
[TBL] [Abstract][Full Text] [Related]
17. A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.
Younossi ZM; Ong JP; Takahashi H; Yilmaz Y; Eguc Hi Y; El Kassas M; Buti M; Diago M; Zheng MH; Fan JG; Yu ML; Wai-Sun Wong V; Alswat K; Chan WK; Mendez-Sanchez N; Burra P; Bugianesi E; Duseja AK; George J; Papatheodoridis GV; Saeed H; Castera L; Arrese M; Kugelmas M; Romero-Gomez M; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1456-e1468. PubMed ID: 34229038
[TBL] [Abstract][Full Text] [Related]
18. Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Based on United States Health Care System.
Vilar-Gomez E; Lou Z; Kong N; Vuppalanchi R; Imperiale TF; Chalasani N
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2305-2314.e12. PubMed ID: 32289535
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting.
Vieira Barbosa J; Lai M
Hepatol Commun; 2021 Feb; 5(2):158-167. PubMed ID: 33553966
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional pilot study to assess primary healthcare workers' knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico.
Vidal-Cevallos P; Ordóñez-Vázquez AL; Procopio-Mosso O; Cardoso-Arias R; Uribe M; Chávez-Tapia NC
Sci Rep; 2021 Jun; 11(1):12100. PubMed ID: 34103552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
